A team of researchers at the University of Toronto has developed the next-generation of a chip-based platform for the identification of infection-causing bacteria.

And while Xagenic, a Canadian molecular diagnostics firm, is commercializing an earlier version of the same platform, the firm could also sell the newer, higher-throughput chip in the future, according to Shana Kelley, chief technical officer at Xagenic and a professor at the University of Toronto.